CRISPR Therapeutics AG - CRSP - stock price prediction, stock price target, analyst ratings from 26 analysts

CRISPR Therapeutics AG has a share price target of US$ 81, revenue growth forecast of -18.1%, and profit growth estimate of -48.1% for FY25, based on top 26 analyst calls.